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Abstract
Purpose
To compare the detection rate of central visual field defect (CVFD) between the 30-degree
Octopus G1 program (Dynamic strategy) and the HFA 10–2 SITA-Standard test in early
glaucoma eyes not showing any CVFD on the HFA 24–2 SITA-Standard test.
Methods
One eye of 41 early glaucoma patients without CVFD in the central 10˚ on HFA 24–2 test
was tested with both the HFA 10–2 test and the Octopus G1 program 15 minutes apart, in
random order. The primary outcome measure was the comparison of CVFD detection rates.
Secondary outcome measures comprised the agreement in detecting CVFD, and the com-
parison of test durations and the numbers of depressed test points outside the central 10-
degree area between the HFA 24–2 test and the Octopus G1 program.
Results
The mean age of the population was 65.2±10.1 years, and the mean deviation with HFA
24–2 was -3.26±2.6 dB. The mean test duration was not significantly different between
the tests (p = 0.13). A CVFD was present in 33 (80.4%) HFA 10–2 test and in 23 (56.0%)
Octopus G1 tests (p = 0.002). The overall agreement between the HFA 10–2 and Octo-
pus G1 examinations in classifying eyes as having or not having CVFD was moderate
(Cohen’s kappa 0.47). The Octopus G1 program showed 69.6% sensitivity and 100%
specificity to detect CVFD in eyes where the HFA 10–2 test revealed a CVFD. The num-
ber of depressed test points (p<5%) outside the central 10˚ area detected with the Octo-
pus G1 program (19.68±10.6) was significantly higher than that detected with the HFA
24–2 program (11.95±5.5, p<0.001).
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Conclusion
Both HFA 10–2 and Octopus G1programs showed CVFD not present at HFA 24–2 test
although the agreement was moderate. The use of a single Octopus G1 examination may
represent a practical compromise for the assessment of both central and peripheral visual
field up to 30˚ eccentricity without any additional testing and increasing the total investigation
time.
Introduction
Glaucoma is one of the leading causes of irreversible blindness [1].
It is characterized by the loss of retinal ganglion cells (RGC) and the corresponding typical
visual field defects [2]. Recent studies showed that glaucomatous changes in the central visual
field may already be present in the early stage of the disease, which is consistent with the results
of imaging studies [3–6]. Thus, detection of early glaucomatous visual field changes at any
eccentricity is important to successful glaucoma detection and management. The 24–2 SITA
test of the Humphrey Field Analyzer (HFA, Carl Zeiss Meditec, Dublin, CA) is one of the most
frequently used tests in clinical practice when normal and glaucomatous eyes need to be sepa-
rated [7]. This fast test employs a grid of 54 test locations evenly distributed with 6˚ separation.
Twelve of the 54 test-point locations are in the central 10˚. Of them 4 locations cover the cen-
tral 8˚ area. However, more than 30% of the retinal ganglion cells reflect the function of this
area [8,9], thus in the HFA 24–2 test the sampling of the central visual field area may be under-
powered. There is a wide agreement between researchers and clinicians that the low spatial res-
olution of this program in the central macular representation might be a major factor of the
underestimation of functional deterioration in glaucoma with this system, independently from
the stage of the disease [10–15].
The central visual field area can be selectively and more accurately tested using the HFA
10–2 test which employs a test-point grid of higher spatial resolution for the assessment of the
central 10-degree visual field area. It has 68 test point locations evenly distributed with 2˚ sepa-
ration in the central 10-degree [8]. Recently it has been shown that the HFA 10–2 program
makes it possible to detect central visual field defects (CVFD) which are not detected with the
HFA 24–2 program already in early glaucoma [10–15]. However, the HFA 10–2 test does not
investigate the peripheral visual field outside the central 10-degree area, thus the patients need
to perform both the 10–2 and the 24–2 tests for optimal decision making, which unfavorably
increases the overall testing time.
In contrast, the G1 program of the Octopus perimeter (Haag-Streit AG, Koeniz-Berne,
Switzerland) employs an unevenly distributed grid of 59 test locations within the 30˚, in which
the test-point density is higher nasally than temporally, and around the macula than in the
more peripheral areas. The Octopus G1 program has 5 central points with 2.8˚ separation for
the fovea representation, and 17 test locations for the macula. This test point distribution
allows both peripheral and the central visual field testing with increased spatial resolution
within the same examination [16].
In the current study, we investigated whether CVFD in the central 10-degree of the visual
field, which is not present at the HFA 24–2 SITA Standard test, can be similarly revealed by
the Octopus G1 test (the general 30-degree glaucoma detection program of the Octopus
perimeter) and by the HFA 10–2 SITA Standard test, which is designed to separately investi-
gate the central 10˚ area of the visual field with increased spatial resolution.
Humphrey vs Octopus perimetry
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Materials and methods
Study population
This cross-sectional study was approved by the ethics committees of University of Rome Tor
Vergata (Registro Sperimentazioni 43.15) and IRCCS Fondazione G.B.Bietti (Registro Speri-
mentazioni N.54/17/FB) where the study was conducted in accordance with the Declaration of
Helsinki.
Patients were recruited between October 2015 and March 2017 among those referring to the
Glaucoma Unit of University of Rome Tor Vergata and to the Glaucoma Unit of IRCCS-Fonda-
zione G.B.Bietti. Patients older than 18 years of age who were able to understand and sign the
written informed consent were enrolled. All participants signed the informed consent prior to
entering the investigation. Forty-six patients were screened to be included in the study. Five of
these patients were excluded because they were not able to perform reliable visual field tests.
The inclusion criteria were the diagnosis of early glaucoma defined with a repeatable HFA
24–2 SITA Standard visual field defect comparable with glaucoma; a Mean Deviation (MD)
value -6 dB; optic nerve head and retinal nerve fiber layer (RNFL) damage which was con-
firmed with spectral domain optical coherence tomography (Spectralis OCT, Heidelberg Engi-
neering, Heidelberg, Germany). The patients had to have sufficient experience in standard
automated perimetry (3 or more reliable tests in the last 2 years). The glaucomatous VF loss
had to be confirmed in at least 2 consecutive tests. It was defined with a glaucoma hemifield
test result outside the normal limits; a MD and pattern standard deviation with p<0.05 proba-
bility of being normal; on the pattern standard deviation plot a cluster of at least 3 contiguous
points of p<0.05 which are not contiguous with the blind spot and do not cross the horizontal
midline; where 1 of the 3 contiguous points had to have p<0.01 of being normal. The visual
fields were classified as reliable if the false positive response rate was <15% and the rate of fixa-
tion losses and false-negative responses was<25%.
The exclusion criteria were the presence of a CVFD within the central 10-degree visual field
area of the HFA-24-2 test, defined with the presence of a cluster of 3 significantly depressed
contiguous points with p<5% in at least 2 test locations, and p<2% in at least 1 test location
within the central 12 test point area; history of any other optic neuropathy; any retinal and
macular disease; optical media opacities that could have biased the functional and structural
test results; spherical refractive error greater than ±6 diopters; and an astigmatism greater than
±3 diopters.
Clinical examination
In the screening visit all patients underwent a detailed comprehensive ophthalmological exam-
ination including the determination of the best corrected visual acuity, slit lamp evaluation, a
HFA 24–2 SITA Standard test (only for patients with the last exam more than 3 months prior
to the study), an IOP measurement with Goldmann applanation tonometry, and indirect oph-
thalmoscopy with a 90 diopters lens via dilated pupils. Additionally, all patients had peripapil-
lary RNFL thickness measurements with the Spectralis SD-OCT 3.5 mm circular scan pattern.
A second visit was scheduled within 2 weeks from the screening visit for the eligible patients,
in which they underwent a HFA 10–2 SITA Standard test and an Octopus G1 Dynamic program
examination on Octopus 900 perimeters using the standard parameters (Goldmann III spot size
and 31.5 dB background luminance) in random order. A 15-minute separation was used between
the tests. When a visual field result was unreliable according to the criteria listed above, a third
visit was scheduled to complete the study. Only eyes with reliable tests were included in the
analysis.
Humphrey vs Octopus perimetry
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Outcomes
The primary outcome of the study was the comparison of the CVFD detection rates between
the HFA 10–2 test and the Octopus G1 program as defined below.
CVFD for both HFA 10–2 and Octopus G1 tests was defined as the presence of a cluster of 3
significantly depressed contiguous points with p<5% on at least 2 test locations and p<2% on at
least 1 test location in the whole grid of the pattern deviation plot of the HFA 10–2 test or within
the 17 central test point locations of the corrected probability plot of the Octopus G1 program.
The secondary outcome measures comprised the agreement of the test outcomes in detect-
ing the presence of a CVFD; the comparison of test durations; and the comparison of the num-
bers of depressed test locations outside the central 10-degree visual field area, between the
HFA 24–2 test and the Octopus G1 program.
Statistical analysis
The statistical analysis was performed using JMP Ver. 9.0.1 (SAS Institute Inc.). Normal distri-
bution of the data was investigated with the Shapiro-Wilk test. Since all variables showed a
normal distribution, mean ± SD was used for descriptive statistics. Analysis of variance for
repeated measures and the paired t-test were used to compare variables. The McNemar test
was used to compare the number and percentage of eyes detected with CVFD between the
tests and Cohen’s kappa was used to calculate the agreement between test classifications. A p
value<0.05 was considered statistically significant.
Results
Forty-one eyes of 41 patients were included in the study. The demographic data of study popu-
lation are reported in Table 1.
The summary of the three test results is reported in Table 2, and a comparative example of
the printouts of the three programs is shown in Fig 1, while Fig 2 shows the central 10 degree
of the visual field with the locations of HFA 24–2, HFA 10–2 and Octopus G1 marked with dif-
ferent symbols.
CVFD was present in 33 (80.4%) HFA 10–2 test and in 23 (56.0%) Octopus G1 tests
(McNemar test, p = 0.002). No eyes without a CVFD on the HFA 10–2 test showed a CVFD
on the Octopus G1 program, while the presence of CVFD in 10 HFA 10–2 tests was not
matched by the Octopus G1 test results. Thirty-one of 41 eyes were classified as having or not
having CVFD, respectively, with both tests (Cohen’s kappa 0.47, Table 3). Considering the
HFA 10–2 test as the index test the Octopus G1 program showed a sensitivity of 69.6% (23/33
eyes) and a specificity of 100% (8/8 eyes) to reveal a CVFD that was not present at the HFA
24–2 test.
Table 1. Demographic data of study population.
N = 43 (mean ± SD)
Age (years) 65.2±10.1 (range: 38–85)
Sex (M/F) 22/19
BCVA (decimal) 9.8±0.4
RNFL Global (μm) 68.8±11.8
IOP (mmHg) 14.7±2.7
SD = standard deviation; M = male; F = female; BCVA = best corrected visual acuity; RNFL = retinal nerve
fiber layer measured with optical coherence tomography; IOP = intraocular pressure.
https://doi.org/10.1371/journal.pone.0186793.t001
Humphrey vs Octopus perimetry
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All eyes (n = 10) with the CVFD detected on the HFA 10–2 but not detected with the Octo-
pus G1 showed visual field defects between 10˚ and 30˚ eccentricities.
The number of depressed test point locations (p<5%) outside the central 10˚area was sig-
nificantly higher with the Octopus G1 program (19.68±10.6) than with the HFA 24–2 test
(11.95±5.5, p<0.001).
The mean test duration was not significantly different between the tests (5.5±0.7 minutes
for the HFA 24–2 test, 5.2±1.1 minutes for the Octopus G1 program, and 5.6±0.8 minutes for
the HFA 10.2 test (ANOVA, p = 0.13). The time needed to perform the Octopus G1 program
was significantly less (paired t-test, p<0.001) than that needed to perform both HFA tests
(11.1±1.3 minutes).
Discussion
It has been shown that the HFA 24–2 test may underestimate the presence of CVFD due to its
low spatial resolution and only 12 test locations in the central 10˚ of the macular area [8].
Table 2. Visual field results with the HFA 24–2 and HFA 10–2 test and the Octopus G1 program.
HFA 24–2 (n = 41) HFA 10–2 (n = 41) Octopus G1 (n = 41)
Number of eyes with CVFD 0 33 (80.4%) 23 (56.0%)
Test time (min) 5.5±0.7 5.6±0.8 5.2±1.1
Mean Deviation Humphrey/Mean Defect Octopus (dB)* -3.26±2.6 -1.67±2.1 4.81±2.8
PSD/sLV (dB) 3.84±2.4 2.20±1.9 4.58±1.7
Number of depressed test locations outside the central 10o area 11.95±5.5 N/A 19.68±10.6
PSD = pattern standard deviation; HFA = Humphrey field analyzer; sLV = square loss variance; CVFD = central visual field defect: MS = mean sensitivity; N/
A = not applicable.
* In Humphrey visual field analysis, the abnormal mean deviation values are negative numbers; in Octopus perimetry the abnormal mean defect values are
positive numbers
https://doi.org/10.1371/journal.pone.0186793.t002
Fig 1. Pattern deviation plots of the Humphrey Field Analyzer (HFA) 24–2 test and the HFA 10–2 test, and the corrected probability
plot of the Octopus G1 program of the same early glaucoma eye from the study. The pattern deviation plot of the HFA 24–2 test shows
no depressed test point within the central 10˚ area (the area surrounded by the cross shape line) but the sensitivity is reduced in the more
peripheral area of the visual field. The pattern deviation plot of the HFA 10–2 test shows a cluster of depressed test point locations. The
peripheral retinal sensitivity is not tested. The corrected probability plot of the Octopus G1 program shows a cluster of reduced sensitivity both
in the central 10˚ area (the region within the inner black circle) and in the periphery.
https://doi.org/10.1371/journal.pone.0186793.g001
Humphrey vs Octopus perimetry
PLOS ONE | https://doi.org/10.1371/journal.pone.0186793 October 27, 2017 5 / 10
Therefore, in the current investigation we compared the ability of the HFA 10–2 SITA Stan-
dard test and the Octopus G1 program, Dynamic strategy for the detection of CVFD in early
Fig 2. Central 10 degrees of the visual field with the locations of HFA 24–2, HFA 10–2 and Octopus G1 plotted in the
same grid. The inner circle delimits the central 10 degrees area with test locations of the three tests (HFA 24–2, HFA 10–2 and
Octopus G1) marked with different symbols. Cross = HFA 24–2; square = HFA 10–2; triangle = Octopus G1.
https://doi.org/10.1371/journal.pone.0186793.g002
Table 3. Agreement of the classification of the central 10-degree visual field between the HFA 10–2 test and the Octopus G1 test.
Octopus G1
Normal Abnormal Total
HFA 10–2 Normal 8 0 8
Abnormal 10 23 33
Total 18 23 41
https://doi.org/10.1371/journal.pone.0186793.t003
Humphrey vs Octopus perimetry
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glaucoma cases where the HFA 24–2 SITA Standard test failed to identify CVFD in the central
10-degree area. The background of our investigation was that glaucoma eyes with normal cen-
tral 10-degree visual field on the HFA 24–2 printout may actually have CVFD [10–15], and
this CVFD may be detected by using programs that employ increased spatial resolution in the
central macular representation. Such programs are the Octopus G1 program and the HFA 10–
2 test. For the Octopus G1 program we used the Dynamic test strategy which is fast and pre-
cious in threshold sensitivity determination [16], while for the HFA 10–2 test we used the
SITA Standard program which is the most commonly used Humphrey strategy in routine clin-
ical practice [7]. As far as we know this is the first study in which such a comparison was
made.
Though CVFD was significantly more frequently found with the HFA 10–2 test than the
Octopus G1 test (80.4% vs. 56.0%), the agreement of classification was substantial since 75.6%
of the eyes was classified consistently by the two tests. In 10 eyes a CVFD was present at the
HFA 10–2 test but not at the Octopus G1 test. Four of these eyes had only one test location
with significantly reduced retinal sensitivity at Octopus G1, while six of these eyes had two
scattered test locations with significantly reduced retinal sensitivity, failing to meet the cluster
criteria applied to define CVFD.
Considering the HFA 10–2 test as the index test the Octopus G1 program had 69.6% sensi-
tivity and 100% specificity for CVFD. The better performance of the Octopus G1 program
over the HFA 24–2 test was expected since the former general glaucoma program uses 59 test
point locations for the total 30-degree tested area, and of them an increased density grid of 17
test point locations is within the macula representation [16]; in contrast the latter test uses 54
test point locations for a 24-degree visual field area, and only 12 of the 54 test points are located
in the central 10˚ [8]. A higher sensitivity of the HFA 10–2 test over the Octopus G1 program
in CVFD detection was also expected since the HFA 10–2 test employs a test-point grid of
high spatial resolution due to its 68 test point locations in the central 10-degree visual field [8].
The high specificity of the Octopus G1 program in CVFD detection suggests that the Octo-
pus G1 program probably does not produce many false positive cases in CVFD detection in
routine clinical practice.
Our results can be considered as a good trade-off between the time spent with visual field
examinations and the efficacy of CVFD detection in early glaucoma. Our results show that in
our early glaucoma population, in which the CVFD remained undetected with the HFA 24–2
test which is the typical primary HFA test for glaucoma in routine practice, the Octopus G1
program alone (mean duration 5.6 minutes per eye) produced an approximately 70% sensitiv-
ity and 100% specificity in the detection of CVFD compared to the HFA 10–2 test, which was
developed for a detailed evaluation of the central 10-degree visual field. Thus, in our early glau-
coma population 70% sensitivity and 100% specificity in CVFD detection was achieved in 5.6
minutes with a single Octopus G1 investigation compared to one HFA 24–2 test and one HFA
10–2 test (total mean duration 11.1 minutes). In addition, all eyes with a CVFD detected on
the HFA 10–2 printout but not detected with the Octopus G1 program were classified as glau-
comatous based on the visual field deterioration between the 10 and 30 degrees eccentricities,
and significantly more abnormal test points were detected with the Octopus G1 program in
this area. Thus, no early glaucoma case was missed.
The importance of accurate testing the retinal sensitivity in the macular area in all glauco-
matous eyes has been highlighted in recent studies exploring the association between quality
of life measures, such as NEI VFQ-25 score, and the visual field status as measured with HFA
10–2 and HFA 24–2 tests [17]. The authors reported that the central 10-degree visual field
appears to have a stronger association with quality of life than findings on the HFA 24–2 tests,
even in the early stages of the disease. Further, a particularly strong association between the
Humphrey vs Octopus perimetry
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HFA 10–2 test results and quality of life was found in those patients that showed low quality of
life despite the presence of early HFA 24–2 damage (expressed as mean sensitivity), suggesting
that they might have undetected macular damage. The macula comprises approximately 30%
of all retinal ganglion cells, and supplies information for 55% to 60% of the primary visual cor-
tex [18]. Thus, it is not unexpected that a damage in the macula can substantially affect the
health-related quality of life [17].
Several studies suggest that in order to increase the detection rate of CVFD, an additional
test specifically designed to investigate the central macular area should be considered across
the whole spectrum of glaucoma severity [10–15]. The HFA 10–2 test comprises 68 locations
spaced 2˚apart in the central 10˚, thus it fulfills the proposed criteria. Hood et al. added two
additional points to the HFA 24–2 test pattern to get the same number of points (9 points) in
the central 10˚ of the upper visual field as for the Octopus G program, and compared the abil-
ity of the grids (HFA 24–2, Octopus G and HFA 24–2+2 test locations) to detect the average
number of abnormal test points with sensitivity -5dB [19]. They found that the Octopus G
program did better than the HFA 24–2 test, but the pattern in which two points were added to
the HFA 24–2 test at -1˚, 5˚ and 1˚, 5˚ positions performed even better. The two points were in
fact arbitrarily added considering the inferior vulnerable macular region studied in a previous
model of glaucomatous damage of the macula [20]. Chen et al collected data on the Medmont
M700 perimeter (Medmont International, Nunawanding) and determined which two loca-
tions could be added to the central 10˚ of the 24–2 pattern to improve the detection of macular
damage due to glaucoma. They found that pairs of locations in the superior macula region
were more often abnormal than pairs in the inferior, thus confirming results of the study by
Hood et al [20,21].
Among the limitations of the present study we should highlight that the presence of poten-
tial artefacts in terms of false positive and false negative test results cannot be completely ruled
out. To try to minimize the presence of false positives and false negatives in our sample popu-
lation we selected only patients already experienced with visual field testing and to improve
the reliability of the detection of CVFD, the cluster criterion for abnormal test locations, rather
than less stringent criteria (such as scattered abnormal test locations, or global indexes), was
chosen to define CVFDs. So, we might have to speak of "matches/mismatches" rather than
defect detections, at least in cases where both protocols had in principle been able to detect a
defect. Moreover, differences in the normative databases of the different perimeters under
investigation in this work may have contributed to the observed differences in the detection
rates of CVFD since the outcome measures chosen to define CVFDs are not absolute measures
of retinal sensitivity but probabilities of abnormality estimated against normative databases.
It must be highlighted also that, as reported in Fig 2, while there are 4 overlaying test loca-
tions between HFA 24–2 and HFA 10–2, there are no overlaying test locations between Octo-
pus G1 and HFA 10–2. Therefore, it is difficult to determine if the mismatch between HFA
10–2 and Octopus G1 in detecting CVFD is due to the lack of spatial correspondence of test
locations of the two grids or is due to the inability of Octopus G1 to detect CVFD detected by
HFA 10–2.
Finally, although it was beyond the scope of the present study, the presence of CVFDs was
not confirmed in this work by the presence of abnormal retinal biomarkers. Future studies
might in fact consider to employ as a confirmation criterion for the presence of CVFD retinal
biomarkers such as RNFL defects in the macular vulnerability zone (i.e. narrow infero-tempo-
ral region of the circumpapillary retinal nerve fiber layer thickness) or the nasalization of the
central retinal vessel trunk location within the optic nerve head [20, 22–24].
The high number of research investigations aiming to increase the ability of the HFA tests
to detect visual field deterioration within the central 10-degree area shows the need of better
Humphrey vs Octopus perimetry
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testing the central macular representation. But at the same time in routine clinical practice
such efforts are limited by the extra time and cost of routine selective macular testing. Thus, a
compromise between sensitivity of CVFD detection and time/cost may also be welcomed in
glaucoma clinics. In this respect using one test that evaluates both the central 10-degree area
and the total 30-degree visual field for glaucomatous deterioration represents a useful tool.
The Octopus G1 program and Dynamic strategy are existing and widely used instruments
which together offer a favorable compromise, as shown by the results of the current investiga-
tion. We think that our results clarify the ability and benefit of using the Octopus G1 program
for the detection of CVFD and peripheral glaucomatous visual field deterioration at the same
time. Since this program is available and therefore offers an immediate support to routine
glaucoma detection we suggest to consider it for primary visual field investigation in glaucoma
detection until more sensitive combined central and peripheral visual field tests become
available.
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